Role of obesity in colorectal carcinogenesis;Az elhízás szerepe a vastagbéldaganatok kialakulásában

Orvosi Hetilap

Volumn 148, Issue 51, 2007, Pages 2411-2416

  Hagymási, Krisztina ^a,b   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Semmelweis Egyetem   (Hungary)

Author keywords

Colorectal cancer; Hyperinsulinemia; Insulin resistance; Insulin like growth factor I; Obesity

Indexed keywords

ADIPOCYTOKINE; SOMATOMEDIN;

CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CYTOKINE RELEASE; DISEASE ASSOCIATION; HIGH RISK PATIENT; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; RISK FACTOR;

EID: 38149065087     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28244     Document Type: Review

References (34)

1. Chung, W. K., Leibel, R. L.: Molecular physiology of syndromic obesities in humans. TRENDS Endocrinol. Metabolism, 2005, 16, 267-272.
2. Liu, Y-J., Xiao, P., Xiong, D. H. és mtsai: Searching for obesity genes. Drugs Today, 2005, 41, 345-362.
3. Mercer, J. G., O'Reilly, L. M., Morgan, P. J.: Increasing the impact of European obesity research in preparation for the European research area: a report on the 2003 European Commission obesity workshop. Obesity Rev., 2004, 5, 79-85.
4. Hall, N. R.: Survival in colorectal cancer: impact of body mass and exercise. Gut, 2006, 55, 8-10.
5. Giovannucci, E., Michaud, D.: The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroentereology, 2007, 132, 2208-2225.
6. Leedham, S. J., Schier, S., Thliveris, A. T. és mtsai: From gene mutations to tumours - stem cells in gastrointestinal carcinogenesis. Cell Prolif., 2005, 38, 387-405.
7. Tulassay Zs. (Szerk.): Gasztroenterológiai Útmutató 2005-Klinikai Irányelvek Kézikönyve. Medition Kiadó, Budapest. 2005, 133-136. old.
8. Watanabe, S., Hojo, M., Nagahara, A.: Metabolic syndrome and gastrointestinal tract diseases. J. Gastroenterol., 2007, 42, 267-274.
9. Johnson, I. T., Lund, E. K.: Review article: nutrition, obesity and colorectal cancer. Aliment. Pharmacol. Ther., 2007, 26, 161-181.
10. Adams, K. F., Leitzmann, M. F., Albanes, D. és mtsai: Body mass and colorectal cancer risk in the NIH-AARP Cohort. Am. J. Epidemiol., 2007, 166, 36-45.
11. Tsushima, M., Nomura, A. M., Lee, J. és mtsa: Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig. Dis. Sci., 2005, 50, 499-505.
12. Wang, J., Gao, Y. T., Wang, X. L.: és mtsai: A prospective cohort study on body mass index and mortality among middle-aged and elderly men in urban Shanghai. Chinese J. Epidemiol., 2005, 26, 394-399.
13. Terry, P. D., Miller, A. B., Rohan, T. E.: Obesity and colorectal cancer risk in women. Gut, 2002, 51, 191-194.
14. Wolf L. A., Terry, P. D., Bostick, R. M.: Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol. Biomarkers Prev., 2007, 16, 676-683.
15. Schoen, R. E., Tangen, C. M., Kuller, L. H. és mtsai: Increased blood glucose and insulin, body size, and incident colorectal cancer. J. Nat. Cancer Inst., 1999, 91, 1147-1154.
16. Sedjo, I. R., Byers, T., Levin, T. R. és mtsai: Change in body size and the risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 526-531.
17. Chung, Y. W., Han, D. S., Park, Y. K. és mtsai: Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig. Liver Dis., 2006, 38, 668-672.
18. Nilsen, T. I., Vatten, L. J.: Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br. J. Cancer, 2001, 84, 417-422.
19. Ehrmann-Josko, A., Siemiska, J., Gornicka, B. és mtsai: Impaired glucose metabolism in colorectal cancer. Scand. J. Gastroenterol., 2006, 41, 1079-1086.
20. Elwing, J. E., Gao, F., Davidson, N. O. és mtsai: Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am. J. Gastroenterol., 2006, 101, 1866-1871.
21. Keku, T. O., Lund, P. K., Galanko, J. és mtsai: Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2076-2081.
22. Platz, E. A., Hankinson, S. E., Rifai, N. és mtsai: Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control, 1999, 10, 379-386.
23. Wei, E. K., Ma, J., Pollak, M. N. és mtsai: C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin and the risk of distal colorectal adenoma in women. Cancer Epidemiol. Biomarkers Prev., 2006, 15, 750-755.
24. Giovannucci, E.: Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J. Women's Health, 2003, 12, 173-182.
25. Limburg, P. J., Stolzenberg-Solomon, R. Z., Vierkant, R. A. és mtsai: Insulin, glucose, insulin resistance and incident of colorectal cancer in male smokers. Clin. Gastroenterol. Hepatol., 2006, 4, 1514-1521.
26. Wei, E. K., Giovannucci, E., Fuchs, C. S. és mtsai: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Nat. Cancer Ins., 2005, 97, 1688-1694.
27. Barish, G. H., Narkar, V. A., Evans, R. M.: PPAR-δ: a dagger in the heart of metabolic syndrome. J. Clin. Invest., 2006, 116, 590-597.
28. Wang, D., Wang, H., Guo, Y és mtsai: Crosstalk between peroxisome proliferator- activated receptor delta and VEGF stimulates cancer progression. Proc. Nat. Acad. Sci. USA, 2006, 103, 19069-19074.
29. Bray, G. A.: How do we get fat? An epidemiologic and metabolic approach. Clin. Dermatol., 2004, 22, 281-288.
30. Statiin, P., Lukanova, A., Biessy, C. és mtsai: Obesity and colon cancer: does leptin provide a link? Int. J. Cancer, 2004, 109, 149-152.
31. Stattin, P., Palmqvist, R., Soderberg, S. és mtsai: Plasma leptin and colorectal cancer risk: prospective study in Northern Sweden. Oncology Reports, 2003, 10, 2015-2021.
32. Kaaks, R., Lukanova, A.: Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. A. N. Y. Acad. Sci., 2002, 963, 268-281.
33. Davies, M., Gupta, S., Goldspink, G. és mtsa: The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence. Int. J. Colorect. Dis., 2006, 21, 201-208.
34. Shao, L., Huang, Q., Luo, M. és mtsa: Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocrine-related Cancer, 2004, 11, 141-148.